Review
doi: 10.1159/000248866.
Short-term and long-term considerations in the management of psoriasis with retinoids
Affiliations
- PMID: 3319723
- DOI: 10.1159/000248866
Item in Clipboard
Review
Short-term and long-term considerations in the management of psoriasis with retinoids
Dermatologica.
1987.
Abstract
Etretinate is a valuable addition to the treatment of psoriasis. Because of its numerous side effects, it should be reserved for only pustular, erythrodermic, and severe cases of plaque-type psoriasis. Many patients whose psoriasis has been recalcitrant to conventional therapy may greatly benefit from this drug.
Similar articles
-
5-Methoxy psoralen, etretinate, and UVA for psoriasis.Int J Dermatol. 1987 Dec;26(10):655-9. doi: 10.1111/j.1365-4362.1987.tb02276.x. Int J Dermatol. 1987. PMID: 3429102 Clinical Trial.
-
Treatment of psoriasis with retinoids: present status.Cutis. 1999 Nov;64(5):347-53. Cutis. 1999. PMID: 10582161 Review.
-
The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.Eur J Dermatol. 2000 Oct-Nov;10(7):517-21. Eur J Dermatol. 2000. PMID: 11056421
-
The retinoids. A review of their clinical pharmacology and therapeutic use.Drugs. 1987 Oct;34(4):459-503. doi: 10.2165/00003495-198734040-00003. Drugs. 1987. PMID: 3315625 Review.
-
Retinoids and psoriasis.Acta Derm Venereol Suppl (Stockh). 1984;112:37-41. Acta Derm Venereol Suppl (Stockh). 1984. PMID: 6596824 No abstract available.
Cited by
-
Comparative tolerability of systemic treatments for plaque-type psoriasis.Drug Saf. 2002;25(13):913-27. doi: 10.2165/00002018-200225130-00003. Drug Saf. 2002. PMID: 12381213 Review.
-
Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.Clin Pharmacokinet. 1992 Jul;23(1):42-61. doi: 10.2165/00003088-199223010-00004. Clin Pharmacokinet. 1992. PMID: 1617858 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical